# usc-section 21 U.S.C. 357

IRI: <https://ontology.bommaritollc.com/id/01a0f06c-ccf9-704b-8dfc-d48a00a01d04>

Type: [adms:Identifier](http://www.w3.org/ns/adms#Identifier)

- `dcterms:conformsTo`: [usc-section](https://ontology.bommaritollc.com/vocab/scheme/usc-section)
- `prov:wasDerivedFrom`: [evidence from https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partA-sec357](https://ontology.bommaritollc.com/id/01a0f06c-ccf8-74ee-81de-0c7a6fd3d099)
- `skos:notation`: 21 U.S.C. 357

## Elsewhere

- [Source](https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partA-sec357) (www.govinfo.gov)

## Pointing here

- Its identifier, from (1; `adms:identifier`):
  - [21 U.S.C. 357 Qualification of drug development tools](https://ontology.bommaritollc.com/id/01a0f06c-ccf8-74ee-81de-0c7ba67cef11)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f06c-ccf9-704b-8dfc-d48a00a01d04.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f06c-ccf9-704b-8dfc-d48a00a01d04.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f06c-ccf9-704b-8dfc-d48a00a01d04.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f06c-ccf9-704b-8dfc-d48a00a01d04)
Cite as: usc-section 21 U.S.C. 357. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f06c-ccf9-704b-8dfc-d48a00a01d04
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
